Phase I Study of Combination With TBI-1401(HF10), a Replication-competent HSV-1 Oncolytic Virus, and Chemotherapy in Japanese Patients With Stage III or IV Unresectable Pancreatic Cancer.
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2018
At a glance
- Drugs Canerpaturev (Primary) ; Gemcitabine; Paclitaxel
- Indications Pancreatic cancer
- Focus Adverse reactions
- Sponsors Takara Bio
- 19 Apr 2018 Planned number of patients changed from 6 to 76.
- 19 Apr 2018 Planned End Date changed from 31 Jan 2019 to 31 May 2020.
- 19 Apr 2018 Planned primary completion date changed from 28 Feb 2018 to 31 May 2020.